Advances in cancer screening
Screening for cancer is an important focus of cancer control. Yet screening, as it involves administering a test to large segments of the population deemed to be at risk for the disease of interest, is potentially a major consumer of scarce health care resources. In addition, the benefits sought from cancer screening, particularly reduction in mortality from the disease, are not always realized, either for biological or organizational reasons. Thus, the paradigm that 'early detection must always be beneficial', taught to health care professionals, and publicized widely through the media to the public, has been challenged in the last two decades for a number of cancer sites. It is the purpose of Advances in Cancer Screening to determine the extent to which the requirements for the introduction of population-based screening programs have been met, as a result of extensive research on screening during the last two decades, with a major concentration on findings from the recent decade.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Principles of economic evaluation in cancer screening
Screening for cervical cancer
Advances in screening for breast cancer
6 other sections not shown
Other editions - View all
adenomas analysis antigen assessment benefit bias BRCA1 breast cancer breast cancer screening breast screening cancer detection cancer incidence cancer syndromes carcinoma case-control study cervical cancer Clin clinical colon cancer colonoscopy colorectal cancer control group cost-effectiveness costs death diagnosis digital rectal examination disease early detection economic evaluation effectiveness of screening Epidemiol estimated evidence family history fecal occult blood FOBT follow-up gastric cancer Gastroenterol gene genetic Hakama Hemoccult hereditary HNPCC incidence rates increased individuals Int J Cancer interval cancers lesions lung cancer malignant melanoma mammography mass screening Miller mortality rates mortality reduction mutations Natl Cancer Inst neuroblastoma occult blood test ovarian cancer overdiagnosis patients polyposis population potential prevalence Prorok PC prostate cancer prostate-specific antigen radical prostatectomy randomized trials reported screen-detected screening cycle screening for cancer screening for colorectal screening interval screening program screening test screening trials sensitivity serum specific stage survival treatment tumor Urol women aged